KPRX   $2.47  -0.40% Market Closed After Close 2.38 -3.64%

Kiora Pharmaceuticals, Inc.
Total Cash 27.82M
totalCashPerShare 9.365
EBITDA 6.32M
Total Debt 82.32K
quickRatio 19.017
currentRatio 19.222
Total Revenue 16.02M
debtToEquity 0.249
Revenue/Share 7.424
ROA 0.12958
ROE 0.13692
grossProfits
freeCashflow 1.47M
operatingCashflow 4.79M
earningsGrowth
revenueGrowth
grossMargins 0.71305
ebitdaMargins 0.39466998
operatingMargins -121.23264
profitMargins 0.19975
enterpriseValue -17.28M
forwardPE -1.5784754
floatShares 1.36M
sharesOutstanding 2.97M
sharesShort 3.61K
sharesShortPriorMonth 5.24K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.48%
Short Ratio help_outline 0.27%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 11.143
Price To Book help_outline 0.32
earningsQuarterlyGrowth
netIncomeToCommon 2.67M
trailingEps 16.53%
forwardEps -2.23%
enterpriseToEbitda -2.73
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.76 3Q 2024
institutionsCount 19
lastUpdated Nov. 7, 2024, 7:01 a.m.